Education
About Us
Working with TipRanks
Follow Us
Josh Mandel-Brehm Insider Profile
4 Followers
Josh Mandel-Brehm, Director at ProMIS Neurosciences, holds ― shares in ProMIS Neurosciences (Ticker: PMN), holds 278.42K shares in CAMP4 Therapeutics Corporation (Ticker: CAMP). Most recently, Josh Mandel-Brehm ― shares of ProMIS Neurosciences on ― for an estimated value of ―.
Josh Mandel-Brehm has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Josh Mandel-Brehm holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Josh Mandel-Brehm
Josh Mandel-Brehm's Trading History
ProMIS Neurosciences
―
Director
―
―
CAMP4 Therapeutics Corporation
Sep 11, 2025
CEO, Director
Informative Buy
10.00K
$904.86K
List of latest transactions for each holding click on a transaction to see Josh Mandel-Brehm's performance on stock
You May Also Like
Josh Mandel-Brehm insider profile FAQ
What is the percentage of profitable transactions made by Josh Mandel-Brehm?
The percentage of profitable transactions made by Josh Mandel-Brehm is ―.
What is the average return per transaction made by Josh Mandel-Brehm?
The average return per transaction made by Josh Mandel-Brehm is ―.
What stocks does Josh Mandel-Brehm hold?
Josh Mandel-Brehm holds: PMN, CAMP stocks.
What was Josh Mandel-Brehm’s latest transaction?
Josh Mandel-Brehm latest transaction was an Uninformative Buy of ―.
What was Josh Mandel-Brehm's most profitable transaction?
Josh Mandel-Brehm’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Josh Mandel-Brehm's role in ProMIS Neurosciences?
Josh Mandel-Brehm's role in ProMIS Neurosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.